BOLD-100

· Bold Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BOLD-100, covering 2025-12-01 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours [Phase 1, Phase 2]